Literature DB >> 3297772

Protein loss during acute graft-versus-host disease: diagnostic and clinical significance.

H F Guiot, J Biemond, E Klasen, J W Gratama, J A Kramps, F E Zwaan.   

Abstract

In 31 consecutive patients who received an allogeneic bone marrow transplantation the loss of proteins during the period at risk for acute graft-versus-host disease (aGVHD) was studied in order to determine whether the quantity of protein loss could be used for grading the severity of aGVHD. It was shown that the grade classified on the basis of the severity of skin rash, the quantity of diarrhea and the seriousness of cholestasis, correlated with serum albumin loss, intestinal plasma loss (expressed by the intestinal alpha 1-antitrypsin clearance) and the occurrence of inflammatory cells (leukocytes) in feces. The quantity of albumin lost by intestinal route accounted for only one third of the total albumin loss. To investigate whether the remaining part of it could be explained by capillary leakage elsewhere in the body, leakage of antileukoprotease from the tissue of the respiratory tract into the blood was measured. It was shown that the serum concentration of this proteinase inhibitor correlated with albumin loss. This means that capillary leakage also occurs in the lung during aGVHD. In conclusion, the loss of proteins can be used as a parameter of the severity of aGVHD once the proper diagnosis has been established. It appears that a combination of the current 'familiar' grading system and SAL yields a more objective classification system with a greater prognostic value.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3297772     DOI: 10.1111/j.1600-0609.1987.tb01160.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  6 in total

1.  Prevention of infection and graft-versus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation.

Authors:  J M Vossen; P J Heidt; H van den Berg; E J Gerritsen; J Hermans; L J Dooren
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-01       Impact factor: 3.267

2.  Enteral nutrition after bone marrow transplantation.

Authors:  A Papadopoulou; A MacDonald; M D Williams; P J Darbyshire; I W Booth
Journal:  Arch Dis Child       Date:  1997-08       Impact factor: 3.791

3.  Gastrointestinal and nutritional sequelae of bone marrow transplantation.

Authors:  A Papadopoulou; D R Lloyd; M D Williams; P J Darbyshire; I W Booth
Journal:  Arch Dis Child       Date:  1996-09       Impact factor: 3.791

4.  Respiratory failure elicited by streptococcal septicaemia in patients treated with cytosine arabinoside, and its prevention by penicillin.

Authors:  H F Guiot; W G Peters; P J van den Broek; J W van der Meer; J A Kramps; R Willemze; R van Furth
Journal:  Infection       Date:  1990 May-Jun       Impact factor: 3.553

Review 5.  Selective decontamination in bone marrow transplant recipients.

Authors:  H F Guiot; R van Furth
Journal:  Epidemiol Infect       Date:  1992-12       Impact factor: 2.451

Review 6.  Host impairments in patients with neoplastic diseases.

Authors:  J Peter Donnelly; Nicole M A Blijlevens; Walter J F M van der Velden
Journal:  Cancer Treat Res       Date:  2014
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.